Nasal Polyps: Causes, Symptoms, and Comprehensive Management

Nasal polyps are chronic inflammatory mucosal protrusions, typically bilateral, arising from the ethmoid sinuses or nasal cavity. They represent a phenotype of chronic rhinosinusitis with nasal polyps (CRSwNP) and are driven by type 2 inflammation (eosinophilia, IL-4, IL-5, IL-13, IgE).

Etiology and Risk Factors

  • Type 2 Inflammation: Eosinophilic infiltration, elevated IgE, local IgE production in sinus tissue.
  • Comorbidities: Asthma (20–40% of CRSwNP), aspirin-exacerbated respiratory disease (AERD: asthma + CRSwNP + NSAID sensitivity), allergic rhinitis, cystic fibrosis (pediatric), primary ciliary dyskinesia.
  • Genetics: Polymorphisms in innate immunity, epithelial barrier, and eosinophil pathways.
  • Environmental: Air pollution, occupational irritants, smoking (mixed evidence), fungal sensitization.
  • Anatomic: Obstructed sinus outflow tracts promote stasis and chronic inflammation.

Clinical Presentation

  • Nasal obstruction/congestion (most common)
  • Anosmia/hyposmia (often earliest and most distressing symptom)
  • Anterior/posterior rhinorrhea
  • Facial pressure/fullness
  • Postnasal drip, throat clearing
  • Snoring, sleep disruption
  • Recurrent acute sinusitis

Diagnosis

  • Nasal endoscopy: translucent, pale, grape-like masses.
  • CT sinuses (Lund-Mackay scoring): opacified ethmoids, osteitic bone remodeling.
  • Allergy testing, spirometry (if asthma suspected), CRP/eosinophils.

Management Algorithm

  1. First-line: Daily intranasal corticosteroid (INS) + high-volume saline irrigation.
  2. Second-line: Short-course oral corticosteroid (if no contraindications) + continue INS.
  3. Third-line (refractory): Biologics (dupilumab, omalizumab, mepolizumab) per endotype/phenotype.
  4. Surgical: FESS for anatomical restoration; adjunctive post-op INS/biologics.

Special Considerations

  • Unilateral Polyps: Neoplasm (inverted papilloma, adenocarcinoma), antrochoanal polyp, foreign body—requires biopsy.
  • Pediatric: Rule out cystic fibrosis (sweat chloride test), primary ciliary dyskinesia.
  • AERD: Aspirin desensitization + daily aspirin 325–650 mg reduces polyp recurrence, asthma exacerbations, and sinus infections.

Chronic condition requiring long-term controller therapy. Multidisciplinary care (rhinologist, allergist, pulmonologist) optimizes outcomes.

Gonorrhea - Related Articles